Disclaimer

The information contained in this section of Oasmia Pharmaceutical AB’s (publ) (the “Company”) website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in Australia, Hong Kong, Japan, Canada, New Zeeland, Singapore, South Africa, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction, and does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Company in Australia, Hong Kong, Japan, Canada, New Zeeland, Singapore, South Africa, the United States or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

Any securities of the Company referred to on this website (the “Securities”) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold within the United States absent registration or pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.

The Securities have also not been and will also not be registered under the applicable securities laws of Australia, Hong Kong, Japan, Canada, New Zeeland, Singapore or South Africa and may not be offered or sold in or into or for the account or benefit of any person having a registered address in, or located or resident in, Australia, Hong Kong, Japan, Canada, New Zeeland, Singapore or South Africa. There are no public offer of the Securities in Australia, Hong Kong, Japan, Canada, New Zeeland, Singapore or South Africa.

Access to the information and documents contained on the following websites may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing outside of Sweden who wish to have access to the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside Sweden. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.

 

Select the country in which you reside:
Please enter your country of residence: